ForeSee growing again, could reach 160 by year’s end
The Ann Arbor company, ForeSee Results Inc., is growing with each click. ForeSee evaluates visitor satisfaction, or dissatisfaction, of large Web sites. And they're doing quite well.
Coverage of innovative research, development and deployment of technology and technological advance, including hardware, software and software as service.
The Ann Arbor company, ForeSee Results Inc., is growing with each click. ForeSee evaluates visitor satisfaction, or dissatisfaction, of large Web sites. And they're doing quite well.
Rising health care costs top the list of employers' concerns from the private to the public sector, so it's logical that a company who can decrease health care costs would be growing. It's certainly the case for Ann Arbor's HealthMedia.
You’ve heard the one about building a better mousetrap – how about building a better mouse? The scientists at Ann Arbor’s GeneVivo are doing just that, pioneering technology that makes it easier to use mice for medical and scientific research.
Mercedes-Benz may have big plans for Ann Arbor. The automaker is considering adding new services to its Ann Arbor facility in addition to an expansion already underway.
General Cable was awarded a major contract to supply the first commercial wind power project in the North Sea.
Threefold Sensors/IA Inc. has developed a test that can provide results in just six minutes, and is using a $400,000 loan from the state's Company Formation and Growth Fund to create eight jobs.
With a $200,000 loan from the state's Company Formation and Growth Fund in hand, Ann Arbor's Meditrina http://www.meditrina.com/Pharmaceuticals is poised to add four positions.
An Arbor Networks expansion will bring 56 new jobs to the Ann Arbor area over the next five years.
Pfizer, Inc., may have closed its doors, but the company continues to investment in Michigan's economy, most recently announcing that $6 million worth of research equipment will be available for life sciences start-ups.
A drug some are calling the female Viagara is one step closer to market. Ophena, developed by Ann Arbor drug company QuatRX Pharmaceuticals Co., was designed to treat a post-menopausal condition that makes sexual activity difficult or painful. QuatRX recently reported good results from a late-stage study.
Our Partners